High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer
-
Published:2019-02-06
Issue:1
Volume:175
Page:217-228
-
ISSN:0167-6806
-
Container-title:Breast Cancer Research and Treatment
-
language:en
-
Short-container-title:Breast Cancer Res Treat
Author:
Bick UlrichORCID, , Engel Christoph, Krug Barbara, Heindel Walter, Fallenberg Eva M., Rhiem Kerstin, Maintz David, Golatta Michael, Speiser Dorothee, Rjosk-Dendorfer Dorothea, Lämmer-Skarke Irina, Dietzel Frederic, Schäfer Karl Werner Fritz, Leinert Elena, Weigel Stefanie, Sauer Stephanie, Pertschy Stefanie, Hofmockel Thomas, Hagert-Winkler Anne, Kast Karin, Quante Anne, Meindl Alfons, Kiechle Marion, Loeffler Markus, Schmutzler Rita K.
Funder
Deutsche Krebshilfe
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference34 articles.
1. Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, Brca Consortium BC, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416.
https://doi.org/10.1001/jama.2017.7112 2. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148(9):671–679 3. Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea MK, Rudas M, Singer CF, Helbich TH (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33(10):1128–1135.
https://doi.org/10.1200/JCO.2014.56.8626 4. Phi XA, Houssami N, Obdeijn IM, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Tilanus-Linthorst MM, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, de Koning HJ, Van den Heuvel ER, de Bock GH (2015) Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age>/= 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol 33(4):349–356.
https://doi.org/10.1200/JCO.2014.56.6232 5. Vreemann S, Gubern-Merida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, Karssemeijer N, Mann RM (2018) Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk. Radiology 286(2):443–451.
https://doi.org/10.1148/radiol.2017170458
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|